ArticleUrologic oncology2018
The effect of socioeconomic status, race, and insurance type on newly diagnosed metastatic prostate cancer in the United States (2004-2013).
Article in Urologic oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Geographical Variations in Prostate Cancer Outcomes: A Systematic Review of International Evidence.Frontiers in oncology · 2019Pooled it
- Choosing Channels, Sources, and Content for Communicating Prostate Cancer Information to Black Men: A Systematic Review of the Literature.American journal of men's health · 2018Pooled it
- Addressing multilevel barriers to clinical trial participation among Black and White men with prostate cancer through the PACCT study.Cancer medicine · 2023Trial
- Sociodemographic trends in prostate cancer: insights from the All of Us Research Program.JNCI cancer spectrum · 2026Article
- Peribronchial cuffing: an underrecognized pattern of prostate carcinoma metastases to the lung.BJC reports · 2026Article
- Racial Differences in Secondary Treatment Pathways and Survival in Localized Prostate Cancer.JAMA network open · 2026Article
- Years of life lost from metastatic prostate cancer according to household income.World journal of urology · 2026Article
- Multilevel associations between prostate cancer testing and socioeconomic position: a population-based register study from Stockholm, Sweden.BMJ public health · 2026Article
- Small cell prostate cancer: risks for metastatic disease.Frontiers in urology · 2026Article
- The Effect of Persistent Poverty on Cancer Outcomes in California.Journal of registry management · 2025Article
- Emerging racial disparities among Medicare beneficiaries and Veterans with metastatic castration-sensitive prostate cancer.Prostate cancer and prostatic diseases · 2024Article
- Are we there yet? Closing the gap of prostate cancer presentation disparities in Ireland.Archives of public health = Archives belges de sante publique · 2024Article
- Article
- Racial, ethnic, and socioeconomic disparities in rates of stage IV prostate cancer after USPSTF category "D" recommendation against prostate-specific antigen screening: a retrospective cohort study.Translational andrology and urology · 2024Article
- Ethnic disparities in cancer mortality in the capital and northeast of the State of São Paulo, Brazil 2001-17.Cancer causes & control : CCC · 2024Article
- Cancer inequalities in incidence and mortality in the State of São Paulo, Brazil 2001-17.Cancer medicine · 2023Article
- Trends in Incidence of Metastatic Prostate Cancer in the US.JAMA network open · 2022Article
- The association of health insurance with the survival of cancer patients with brain metastases at diagnosis.Technical innovations & patient support in radiation oncology · 2021Article
- Factors impacting the time to ovarian cancer diagnosis based on classic symptom presentation in the United States.Cancer · 2021Article
- The association of low socioeconomic status with advanced stage thyroid cancer.Journal of Taibah University Medical Sciences · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundUnderstanding the characteristics of men who initially present with metastatic prostate cancer (mPCa) can better enable directed improvement initiatives. The objective of this study was to assess the relationship between socioeconomic status (SES) and newly diagnosed mPCa. MATERIALS
methodsAll men diagnosed with PCa in the National Cancer Data Base from 2004 to 2013 were identified. Characteristics of men presenting with and without metastatic disease were compared. A 4-level composite metric of SES was created using Census-based income and education data. Multivariable logistic regression was used to evaluate the association between SES, race/ethnicity, and insurance and the risk of presenting with mPCa at the time of diagnosis.
resultsOf 1,034,754 patients diagnosed with PCa, 4% had mPCa at initial presentation. Lower SES (first vs. fourth quartile; odds ratio [OR] = 1.39, 95% CI: 1.35-1.44), black and Hispanic race/ethnicity (vs. white; OR = 1.47, 95% CI: 1.43-1.51 and OR = 1.22, 95% CI: 1.17-1.28, respectively), and having Medicaid or no insurance (vs. Medicare or private; OR = 3.91, 95% CI: 3.78-4.05) were each independently associated with higher odds of presenting with mPCa after adjusting for all other covariates.
conclusionsLower SES, race/ethnicity, and having Medicaid or no insurance were each independently associated with higher odds of presenting with metastases at the time of PCa diagnosis. Our findings may partially explain current PCa outcomes disparities and inform future efforts to reduce disparities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.